The unpluggable in pursuit of the undruggable: tackling the dark matter of the cancer therapeutics universe
The notion that targeted drugs can unplug gain-of-function tumor pathways has revitalized pharmaceutical research, but the survival benefits of this strategy have so far proven modest. A weakness of oncogene-blocking approaches is that they do not address the problem of cancer progression as selecte...
Main Author: | Richard J. Epstein |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00304/full |
Similar Items
-
Apoptotic and antioxidant activities of extracts of Spondias monbin stem bark in dimethylhydrazine (DMH)-induced colorectal carcinogenesis in Wistar rats
by: O. Ikponmwosa-Eweka, et al.
Published: (2023-11-01) -
The Effect of 5-Aza-2′-Deoxycytidine in Combination to and in Comparison with Vorinostat on DNA Methyltransferases, Histone Deacetylase 1, Glutathione S-Transferase 1 and Suppressor of Cytokine Signaling 1 Genes Expression, Cell Growth Inhibition and Apop
by: Masumeh Sanaei, et al.
Published: (2020-01-01) -
Discovering the role of FZD4 Gene in human cutaneous squamous cell carcinoma
by: Ke Zhang, et al.
Published: (2021-01-01) -
The expression and function of long noncoding RNAs in hepatocellular carcinoma
by: Jingli Du, et al.
Published: (2023-12-01) -
miR-106b as an emerging therapeutic target in cancer
by: Surendra Kumar Sagar
Published: (2022-07-01)